6,486 Studies Reviewed. 85.2% of Original Studies Found Biological Effects. The Evidence is Clear.

Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson's disease.

Bioeffects Seen

Dileone M, Carrasco-López MC, Segundo-Rodriguez JC, Mordillo-Mateos L, López-Ariztegui N, Alonso-Frech F, Catalan-Alonso MJ, Obeso JA, Oliviero A, Foffani G, · 2017

View Original Abstract
Share:

tSMS significantly decreased MEP amplitudes in patients off medication but not on medication, suggesting dopamine-dependent changes in cortical excitability.

Plain English Summary

Summary written for general audiences

Researchers performed a randomized double-blind sham-controlled cross-over study applying tSMS for 10 minutes to the more affected motor cortex of Parkinson's disease patients. Cortical excitability was measured by motor evoked potential amplitude elicited by single-pulse transcranial magnetic stimulation. tSMS significantly decreased MEP amplitudes in patients off dopaminergic medication but not in patients on levodopa. Between-patient variability of tSMS-induced changes was significantly greater when patients were on medication. Greater disease progression was associated with a switch from inhibitory to facilitatory plasticity on medication.

Why This Matters

The study aimed to test whether tSMS could modulate cortical excitability in Parkinson's disease patients. The results suggest that tSMS induces dopamine-dependent changes of cortical excitability in patients with Parkinson’s disease.

Exposure Information

Specific exposure levels were not quantified in this study. Duration: 10 min

Study Details

The objective of the present study was to test the ability of tSMS to modulate cortical excitability in patients with Parkinson’s disease.

We performed a randomized double-blind sham-controlled cross-over study to assess cortical excitabil...

tSMS significantly decreased MEP amplitudes in patients OFF medication (after overnight withdrawal o...

These results suggest that tSMS induces dopamine-dependent changes of cortical excitability in patients with Parkinson’s disease.

Cite This Study
Dileone M, Carrasco-López MC, Segundo-Rodriguez JC, Mordillo-Mateos L, López-Ariztegui N, Alonso-Frech F, Catalan-Alonso MJ, Obeso JA, Oliviero A, Foffani G, (2017). Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson's disease. Sci Rep. 7(1):4329, 2017.
Show BibTeX
@article{m_2017_dopaminedependent_changes_of_cortical_1738,
  author = {Dileone M and Carrasco-López MC and Segundo-Rodriguez JC and Mordillo-Mateos L and López-Ariztegui N and Alonso-Frech F and Catalan-Alonso MJ and Obeso JA and Oliviero A and Foffani G and},
  title = {Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson's disease.},
  year = {2017},
  
  url = {https://www.nature.com/articles/s41598-017-04254-y},
}

Quick Questions About This Study

The study was a randomized double-blind sham-controlled cross-over trial applying tSMS for 10 minutes to the more affected motor cortex.
tSMS significantly decreased MEP amplitudes in patients off dopaminergic medication.
tSMS did not significantly decrease MEP amplitudes in patients on levodopa, and between-patient variability was greater on medication.
More advanced disease was associated with a switch from inhibitory to facilitatory plasticity when patients were on medication.
The results suggest that tSMS induces dopamine-dependent changes in cortical excitability in Parkinson's disease.